Form 4: Director Cain Hayes Awarded EHC Restricted Stock Units

Encompass Health Director Cain A. Hayes received an award of 457 restricted stock units under the company's 2025 Omnibus Performance Incentive Plan.

Summary

• Cain A. Hayes, a Director of Encompass Health Corp (EHC), was awarded 457 shares of common stock.
• The transaction occurred on January 30, 2026, with a transaction price of $0 per share, indicating an award rather than a purchase.
• This award represents restricted stock units granted pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
• Following this transaction, Cain A. Hayes directly beneficially owns 457 shares of Encompass Health Common Stock.
• A Power of Attorney, effective January 29, 2026, designates Patrick Darby and Stephen Leasure as attorneys-in-fact for SEC filings, and Stephen Leasure and Philip Calagaz for EDGAR system management, on behalf of Cain A. Hayes.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive administrative filing. While not directly impacting immediate financial performance, it reflects standard corporate governance and compensation practices, aligning director interests with long-term company success.

Positives

• The award of 457 restricted stock units aligns the director's interests with long-term shareholder value.
• The grant under the 2025 Omnibus Performance Incentive Plan indicates a structured approach to executive and director compensation.

Risks

• No specific risks related to the company's operations or financial health are disclosed in this Form 4 or the associated Power of Attorney.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that the award of restricted stock units to a director is a common practice in the healthcare services industry, aligning executive and director incentives with long-term company performance and shareholder interests. This type of compensation is a standard component of corporate governance for publicly traded companies like Encompass Health.

Comparison to Industry Standards

• The grant of restricted stock units to directors is a standard compensation mechanism across various industries, including healthcare, often used by companies such as HCA Healthcare, Universal Health Services, and Tenet Healthcare to retain talent and align interests.
• The specific number of units (457) would typically be determined by a compensation committee based on factors like director responsibilities, company size, and peer group compensation benchmarks, though these details are not provided in this filing.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU award aligns the director's interests with long-term shareholder value, as the value of the award is tied to the company's stock performance.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine restricted stock unit award to a director, which is a standard compensation practice and does not provide new information that would significantly alter the investment thesis for Encompass Health Corp. It reflects ongoing corporate governance and compensation alignment but does not indicate a material change in the company's operational or financial outlook. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific administrative filing.

Keywords

Encompass Health, EHC, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Award, Corporate Governance